Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5J89

Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor

Summary for 5J89
Entry DOI10.2210/pdb5j89/pdb
DescriptorProgrammed cell death 1 ligand 1, N-{2-[({2-methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]pyridin-3-yl}methyl)amino]ethyl}acetamide, 1,2-ETHANEDIOL, ... (4 entities in total)
Functional Keywordspd-l1, programmed cell death 1 ligand 1, cell cycle, immune system
Biological sourceHomo sapiens (Human)
Cellular locationIsoform 1: Cell membrane ; Single-pass type I membrane protein . Isoform 2: Endomembrane system ; Single-pass type I membrane protein : Q9NZQ7
Total number of polymer chains4
Total formula weight67838.12
Authors
Zak, K.M.,Grudnik, P.,Guzik, K.,Zieba, B.J.,Musielak, B.,Doemling, P.,Dubin, G.,Holak, T.A. (deposition date: 2016-04-07, release date: 2016-04-27, Last modification date: 2024-11-13)
Primary citationZak, K.M.,Grudnik, P.,Guzik, K.,Zieba, B.J.,Musielak, B.,Domling, A.,Dubin, G.,Holak, T.A.
Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).
Oncotarget, 7:30323-30335, 2016
Cited by
PubMed Abstract: Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has provided unprecedented results in cancer treatment in the recent years. Development of chemical inhibitors for this pathway lags the antibody development because of insufficient structural information. The first nonpeptidic chemical inhibitors that target the PD-1/PD-L1 interaction have only been recently disclosed by Bristol-Myers Squibb. Here, we show that these small-molecule compounds bind directly to PD-L1 and that they potently block PD-1 binding. Structural studies reveal a dimeric protein complex with a single small molecule which stabilizes the dimer thus occluding the PD-1 interaction surface of PD-L1s. The small-molecule interaction "hot spots" on PD-L1 surfaces suggest approaches for the PD-1/PD-L1 antagonist drug discovery.
PubMed: 27083005
DOI: 10.18632/oncotarget.8730
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon